UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.48B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$690M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$588M |
| 4 |
Truist Financial
TFC
|
+$532M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.3B |
| 2 |
Alibaba
BABA
|
+$771M |
| 3 |
AABA
Altaba Inc
AABA
|
+$759M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$503M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.82% |
| 2 | Financials | 7.38% |
| 3 | Healthcare | 6.65% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Industrials | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5176
Quanterix
QTRX
$114M
| $343K | ﹤0.01% |
14,507
+11,216
| +341% | +$256K |
|
5177
State Street SPDR MSCI ACWI Climate Paris Aligned ETF
NZAC
$198M
| $342K | ﹤0.01% |
13,820
-1,636
| -11% | -$39.1K |
|
|
EGRX
5178
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $342K | ﹤0.01% |
5,678
-20,760
| -79% | -$1.24M |
|
|
DPLO
5179
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $342K | ﹤0.01% |
85,575
-994,792
| -92% | -$4.67M |
|
5180
Mistras Group
MG
$502M
| $341K | ﹤0.01% |
23,939
+10,255
| +75% | +$145K |
|
|
GHL
5181
DELISTED
Greenhill & Co., Inc.
GHL
| $341K | ﹤0.01% |
19,965
+7,439
| +59% | +$121K |
|
|
GTS
5182
DELISTED
Triple-S Management Corporation
GTS
| $341K | ﹤0.01% |
18,441
+1,598
| +9% | +$27.2K |
|
|
ABTX
5183
DELISTED
Allegiance Bancshares
ABTX
| $340K | ﹤0.01% |
9,065
-9,162
| -50% | -$323K |
|
5184
PUT
Boston Scientific
BSX
$73.1B
| $339K | ﹤0.01% |
7,500
+4,600
| +159% | +$192K |
|
|
ITIC
5185
Investors Title Co
ITIC
$540M
| $339K | ﹤0.01% |
2,127
+257
| +14% | +$41.6K |
|
|
BWIN
5186
Baldwin Insurance Group
BWIN
$2.79B
| $339K | ﹤0.01% |
+21,121
| New | +$337K |
|
|
TAST
5187
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $339K | ﹤0.01% |
48,022
+13,946
| +41% | +$102K |
|
5188
VirnetX Holding Corp
VHC
$60M
| $338K | ﹤0.01% |
4,449
+1,383
| +45% | +$139K |
|
5189
Alpha and Omega Semiconductor
AOSL
$1.03B
| $337K | ﹤0.01% |
24,725
+7,194
| +41% | +$90.9K |
|
5190
Phreesia
PHR
$769M
| $337K | ﹤0.01% |
12,665
+3,788
| +43% | +$105K |
|
5191
Solid Biosciences
SLDB
$918M
| $337K | ﹤0.01% |
5,048
-377
| -7% | -$41.6K |
|
|
PBIP
5192
DELISTED
Prudential Bancorp, Inc.
PBIP
| $337K | ﹤0.01% |
18,166
+2,402
| +15% | +$42.4K |
|
5193
Datadog
DDOG
$93.6B
| $336K | ﹤0.01% |
8,876
+8,091
| +1,031% | +$291K |
|
|
PS
5194
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $336K | ﹤0.01% |
19,493
-11,210
| -37% | -$191K |
|
5195
Colliers International
CIGI
$5.11B
| $335K | ﹤0.01% |
4,290
-3,882
| -48% | -$280K |
|
5196
EPR Properties 5.75% Series C Preferred Shares
EPR.PRC
$145M
| $335K | ﹤0.01% |
10,665
+9,832
| +1,180% | +$321K |
|
5197
Omega Flex
OFLX
$306M
| $335K | ﹤0.01% |
3,125
+977
| +45% | +$95.3K |
|
5198
iShares MSCI Denmark ETF
EDEN
$204M
| $334K | ﹤0.01% |
4,845
+2,140
| +79% | +$138K |
|
5199
Vera Bradley
VRA
$96.4M
| $334K | ﹤0.01% |
28,281
+17,602
| +165% | +$195K |
|
|
VRTV
5200
DELISTED
VERITIV CORPORATION
VRTV
| $334K | ﹤0.01% |
16,968
+5,175
| +44% | +$90.3K |
|
Similar funds
UBS Group's Q4 2019 Portfolio in Review
As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
- UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
- UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
- UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
- UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
- UBS Group opened 808 new positions and closed 688 in Q4 2019.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.